journal
MENU ▼
Read by QxMD icon Read
search

Current Opinion in Hematology

journal
https://www.readbyqxmd.com/read/30407218/the-role-of-cxcr2-in-acute-inflammatory-responses-and-its-antagonists-as-anti-inflammatory-therapeutics
#1
Xiaoyu Zhang, Rongxia Guo, Hiroto Kambara, Fengxia Ma, Hongbo R Luo
PURPOSE OF REVIEW: CXCR2 is key stimulant of immune cell migration and recruitment, especially of neutrophils. Alleviating excessive neutrophil accumulation and infiltration could prevent prolonged tissue damage in inflammatory disorders. This review focuses on recent advances in our understanding of the role of CXCR2 in regulating neutrophil migration and the use of CXCR2 antagonists for therapeutic benefit in inflammatory disorders. RECENT FINDINGS: Recent studies have provided new insights into how CXCR2 signaling regulates hematopoietic cell mobilization and function in both health and disease...
November 6, 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30394900/the-clinical-consequences-of-neutrophil-priming
#2
Katja L Vogt, Charlotte Summers, Alison M Condliffe
PURPOSE OF REVIEW: Neutrophils priming has been long studied in vitro. Recent studies describe it in vivo. In pathophysiological conditions, complex, heterogeneous characteristics of priming are described in the last few years. RECENT FINDINGS: Priming can occur systemically when insults such as sepsis or trauma result in an array of circulating mediators and circulating primed neutrophils seem to exert detrimental effects either directly, or indirectly by interacting with other cells, thereby contributing to the development of organ dysfunction...
November 1, 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30281037/towards-increasing-shelf-life-and-haemostatic-potency-of-stored-platelet-concentrates
#3
Shailaja Hegde, Huzoor Akbar, Yi Zheng, Jose A Cancelas
PURPOSE OF REVIEW: Platelet transfusion is a widely used therapy in treating or preventing bleeding and haemorrhage in patients with thrombocytopenia or trauma. Compared with the relative ease of platelet transfusion, current practice for the storage of platelets is inefficient, costly and relatively unsafe, with platelets stored at room temperature (RT) for upto 5-7 days. RECENT FINDINGS: During storage, especially at cold temperatures, platelets undergo progressive and deleterious changes, collectively termed the 'platelet storage lesion', which decrease their haemostatic function and posttransfusion survival...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30281036/restoring-antiviral-immunity-with-adoptive-transfer-of-ex-vivo-generated-t-cells
#4
Edoardo Migliori, Mark Chang, Pawel Muranski
PURPOSE OF REVIEW: Latent viruses such as cytomegalovirus (CMV), Epstein-Barr virus (EBV) and adenovirus (ADV) often reactivate in immunocompromised patients, contributing to poor clinical outcomes. A rapid reconstitution of antiviral responses via adoptive transfer of virus-specific T cells (VSTs) can prevent or eradicate even refractory infections. Here, we evaluate this strategy and the associated methodological, manufacturing and clinical advances. RECENT FINDINGS: From the early pioneering but cumbersome efforts to isolate CMV-specific T cell clones, new approaches and techniques have been developed to provide quicker, safer and broader-aimed ex-vivo antigen-specific cells...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30281035/to-transfuse-or-not-transfuse-an-intensive-appraisal-of-red-blood-cell-transfusions-in-the-icu
#5
Margaret M Hayes, Lynne Uhl
PURPOSE OF REVIEW: This review is a critical appraisal of the current data comparing restrictive vs. liberal transfusion strategies for patients who are critically ill in ICUs. We focus on four subsets of critically ill patients: pediatric patients, patients with gastrointestinal bleeds, septic patients and patients undergoing cardiac surgery. RECENT FINDINGS: Almost a decade after the TRICC trial, a randomized trial showing the safety of a restrictive transfusion threshold in critically ill patients, four large randomized controlled trials have shown that a restrictive transfusion strategy is safe in pediatric critically ill patients, patients with acute upper gastrointestinal bleeds, patients with septic shock and patients undergoing cardiac surgery...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30281034/when-might-transferrin-hemopexin-or-haptoglobin-administration-be-of-benefit-following-the-transfusion-of-red-blood-cells
#6
Paul W Buehler, Elena Karnaukhova
PURPOSE OF REVIEW: After transfusion, a percentage of red blood cells undergo hemolysis within macrophages. Intravascular exposures to hemin and hemoglobin (Hb) can occur after storage bag hemolysis, some transfusion reactions, during use of medical assist devices and in response to bacterial hemolysins. Proteins that regulate iron, hemin and Hb either become saturated after iron excess (transferrin, Tf) or depleted after hemin (hemopexin, Hpx) and Hb (haptoglobin, Hp) excess. Protein saturation or stoichiometric imbalance created by transfusion increases exposure to non-Tf bound iron, hemin and Hb...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30281033/next-generation-sequencing-based-minimal-residual-disease-monitoring-in-patients-receiving-allogeneic-hematopoietic-stem-cell-transplantation-for-acute-myeloid-leukemia-or-myelodysplastic-syndrome
#7
Roman M Shapiro, Dennis Dong Hwan Kim
PURPOSE OF REVIEW: The monitoring of minimal residual disease (MRD) has important clinical implications in both the pre and postallogeneic stem cell transplant (SCT) setting in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Next-generation sequencing (NGS) is a rapidly improving technology whose application to the monitoring of MRD is an active area of research. We aim to describe existing methods of MRD in AML and MDS, with a focus on the utility of NGS in patients undergoing SCT...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30239378/current-and-future-status-of-stem-cell-expansion
#8
Melody Becnel, Elizabeth J Shpall
PURPOSE OF REVIEW: Herein, we seek to describe the current and future role of ex-vivo expansion of cord blood hematopoietic stem cells. RECENT FINDINGS: As this field is only in its infancy, there have been many challenges identified. Decreased number of stem cells contained in a cord blood unit and early differentiation of stem cells once expanded have been two overarching challenges faced by the field. Many recent techniques have focused on the properties of the microenvironment and targetable cellular pathways as novel approaches to circumvent these challenges...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30239377/the-clinical-impact-of-glucose-6-phosphate-dehydrogenase-deficiency-in-patients-with-sickle-cell-disease
#9
Matthew S Karafin, Xiaoyun Fu, Angelo D'Alessandro, Tiffany Thomas, Eldad A Hod, James C Zimring, Joshua J Field, Richard O Francis
PURPOSE OF REVIEW: Glucose-6-phosphate dehydrogenase (G6PD) deficiency and sickle cell disease (SCD) cause hemolysis, often occurring in individuals of African descent. These disorders co-occur frequently, and possibly interact, altering clinical outcomes in SCD. However, epidemiological investigations of SCD with G6PD deficiency have produced variable results. This contribution reviews the available data about the interaction of G6PD deficiency and SCD. RECENT FINDINGS: Overall, G6PD deficiency contributes few, if any, effects to laboratory values and clinical outcomes in SCD patients, but may impact transfusion efficacy...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30169458/murine-models-of-autoimmune-hemolytic-anemia
#10
Heather L Howie, Krystalyn E Hudson
PURPOSE OF REVIEW: Pathogenic autoantibodies directed against red blood cells (RBCs) may lead to autoimmune hemolytic anemia (AIHA), a severe and sometimes fatal disease. Much of what is known about the etiology and pathogenesis of AIHA has been learned from observations made in human patients and murine models, but many questions remain; importantly, it is still unclear why some people generate RBC-specific autoantibodies. The combination of technological advancements applied to existing models and the development of new AIHA murine models will continue to provide considerable insight into the initiation of AIHA and provide a platform for the design of more effective therapies...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30157069/hematopoietic-stem-cell-transplantation-for-autoimmune-diseases-more-than-just-prolonged-immunosuppression
#11
Alan Tyndall
PURPOSE OF REVIEW: To summarize the current clinical experience in the use of autologous hematopoietic stem cell transplantation (HSCT) in autoimmune disease and to explore the concept of durable remission induction and tissue de-remodeling via restoration of normal niche function and "immune reset.' RECENT FINDINGS: Controlled clinical trials in systemic sclerosis, multiple sclerosis, and Crohn's disease as well as extensive uncontrolled trial and registry data have established the unique role of HSCT in selected cases...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30148720/microtransplantation-clinical-applications-and-mechanisms
#12
Bo Cai, Mei Guo, Huisheng Ai
PURPOSE OF REVIEW: Microtransplantation (MST) has been successfully used to manage patients with hematological malignancies, especially older patients with acute myeloid leukemia (AML). Recent clinical applications and mechanistic studies of MST are reviewed. RECENT FINDINGS: MST improves complete remission rates which have no significant difference among age groups in older patients with AML. Sufficient courses of postremission therapy lead to prolonged overall survival and reduced relapse rate...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30138126/the-role-of-genomics-in-transfusion-medicine
#13
Marsha M Wheeler, Jill M Johnsen
PURPOSE OF REVIEW: To summarize recent advances in red blood cell (RBC) blood group genotyping, with an emphasis on advances in the use of NGS next generation sequencing (NGS) to detect clinically relevant blood group gene variation. RECENT FINDINGS: Genetic information is useful in predicting RBC blood group antigen expression in several clinical contexts, particularly, for patients at high-risk for allosensitization, such as multiple transfused patients. Blood group antigen expression is directed by DNA variants affecting multiply genes...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30124476/age-related-clonal-hematopoiesis-implications-for-hematopoietic-stem-cell-transplantation
#14
Sagi Abelson, Jean C Y Wang
PURPOSE OF REVIEW: Over the past decade, advances in hematopoietic stem cell transplantation (HSCT) have enabled older individuals to undergo the procedure as well as to serve as donors. Recently, aging has been linked with the development of age-related clonal hematopoiesis (ARCH), defined as the gradual clonal expansion of hematopoietic stem and progenitor cells (HSPC) carrying recurrent disruptive genetic variants in individuals without a diagnosis of hematologic malignancy. Here we will review the implications of ARCH in the context of HSCT...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30124475/-massive-transfusion-protocols-and-the-use-of-tranexamic-acid
#15
Elizabeth A Godbey, Joseph Schwartz
PURPOSE OF REVIEW: We review recent articles pertaining to the use of tranexamic acid (TXA) in populations at risk for massive transfusion. Although there are no recent studies that specifically examine the use of TXA in massive transfusion protocols (MTPs), there are a few studies with subgroups of massive transfusion patients. RECENT FINDINGS: In recent years, many publications have discussed outcomes and safety associated with the addition of TXA to treatment plans for bleeding pediatric, trauma, and postpartum hemorrhage patients...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30124474/delayed-haemolytic-and-serologic-transfusion-reactions-pathophysiology-treatment-and-prevention
#16
Alexa J Siddon, Barton C Kenney, Jeanne E Hendrickson, Christopher A Tormey
PURPOSE OF REVIEW: The aim of this study was to summarize the basic epidemiology, pathophysiology and management of delayed serologic and delayed haemolytic transfusion reactions (DHTRs), as well as recent developments in our understanding of these adverse events. RECENT FINDINGS: Several studies have identified risk factors for DHTRs, including high alloantibody evanescence rates among both general patient groups and those with sickle cell disease (SCD). Antibody detection is also hampered by the phenomenon of transfusion record fragmentation...
November 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30067573/editorial-introduction
#17
(no author information available yet)
No abstract text is available yet for this article.
September 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30028742/the-plasma-contact-system-as-a-modulator-of-innate-immunity
#18
Yi Wu
PURPOSE OF REVIEW: The contact system is a plasma protease cascade, which activates the proinflammatory kallikrein-kinin system and the procoagulant intrinsic coagulation pathway. Recent advances demonstrating the novel functions of this system as a key player of innate immune system will be introduced in the present review. RECENT FINDINGS: The role of the contact system is to initiate and participate in pathophysiological responses to injury, mainly the processes of coagulation and inflammation...
September 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30028741/subverting-bradykinin-evoked-inflammation-by-co-opting-the-contact-system-lessons-from-survival-strategies-of-trypanosoma-cruzi
#19
Julio Scharfstein
PURPOSE OF REVIEW: During Chagas disease, Trypanosoma cruzi alternates between intracellular and extracellular developmental forms. After presenting an overview about the roles of the contact system in immunity, I will review experimental studies showing that activation of the kallikrein-kinin system (KKS) translates into mutual benefits to the host/parasite relationship. RECENT FINDINGS: T. cruzi trypomastigotes initiate inflammation by activating tissue-resident innate sentinel cells via the TLR2/CXCR2 pathway...
September 2018: Current Opinion in Hematology
https://www.readbyqxmd.com/read/30015643/emerging-applications-of-aptamers-for-anticoagulation-and-hemostasis
#20
Charlene V Chabata, James W Frederiksen, Bruce A Sullenger, Ruwan Gunaratne
PURPOSE OF REVIEW: Since the selection of the first thrombin-binding aptamer in 1992, the use of nucleic acid aptamers to target specific coagulation factors has emerged as a valuable approach for generating novel anticoagulant and procoagulant therapeutics. Herein, we highlight the most recent discoveries involving application of aptamers for those purposes. RECENT FINDINGS: Learning from the successes and pitfalls of the FIXa-targeting aptamer pegnivacogin in preclinical and clinical studies, the latest efforts to develop antidote-controllable anticoagulation strategies for cardiopulmonary bypass that avoid unfractionated heparin involve potentiation of the exosite-binding factor X (FX)a aptamer 11F7t by combination with either a small molecule FXa catalytic site inhibitor or a thrombin aptamer...
September 2018: Current Opinion in Hematology
journal
journal
31918
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"